Aug 27 (Reuters) - The U.S. Food and Drug Administration

has approved updated COVID-19 vaccines for all people aged 65

and older and for people under 65 with higher health risks, the

U.S. health secretary said on Wednesday.

The U.S. Department of Health and Human Services did not

immediately respond to a Reuters request for comment. The three

approved shots are made by Pfizer ( PFE ) with German partner

BioNTech, Moderna ( MRNA ), and Novavax ( NVAX ).

Pfizer ( PFE ) said the emergency use authorization for its COVID

vaccine for children under age 5 had been rescinded.

Moderna's ( MRNA ) shot was approved for ages 6 months and up, Health

Secretary Robert F. Kennedy Jr. said. Moderna ( MRNA ) was not

immediately available for comment.

Pfizer ( PFE ) and BioNTech's updated version of Comirnaty was

approved for everyone 65 and over, as well as in individuals

ages 5 through 64 years with at least one underlying condition

that puts them at high risk for severe outcomes from COVID

infection, the company said in a press release.